Telix Pharmaceuticals (TLX) Intangibles (2023 - 2024)
Telix Pharmaceuticals' Intangibles came in at $272.13 million for the quarter ended Dec 31, 2024, up 281.2% from $71.39 million a year earlier.
Powered by 
Analysis
Telix Pharmaceuticals (TLX) Intangibles (2023 - 2024) Analysis & Trends
- Going back by year, Intangibles was $71.39 million in the year ended Dec 31, 2023 (+74.1%) and $41 million in the year ended Dec 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,226.47 Bn | 1,195.05 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 664.23 Bn | 584.09 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 513.30 Bn | 486.41 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 362.25 Bn | 316.63 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 270.37 Bn | 244.05 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.26 Bn | 204.66 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 204.81 Bn | 179.01 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Telix Pharmaceuticals | 3.21 Bn | 2.17 Bn | - | - |
API Access
Telix Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=TLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "TLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=TLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();